Nordwand Advisors, LLC Johnson & Johnson Transaction History
Nordwand Advisors, LLC
- $266 Billion
- Q1 2025
A detailed history of Nordwand Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nordwand Advisors, LLC holds 591,684 shares of JNJ stock, worth $92.6 Million. This represents 36.84% of its overall portfolio holdings.
Number of Shares
591,684
Previous 591,684
-0.0%
Holding current value
$92.6 Million
Previous $85.6 Billion
14.67%
% of portfolio
36.84%
Previous 35.25%
Shares
8 transactions
Others Institutions Holding JNJ
# of Institutions
4,657Shares Held
1.73BCall Options Held
25MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA234MShares$36.6 Billion0.72% of portfolio
-
Black Rock Inc. New York, NY198MShares$31 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$20.9 Billion0.94% of portfolio
-
Geode Capital Management, LLC Boston, MA59.4MShares$9.29 Billion0.79% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$8.46 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $409B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...